Your browser is no longer supported. Please, upgrade your browser.
Settings
BIVI [NASD]
BioVie Inc.
Index- P/E- EPS (ttm)-11.72 Insider Own0.30% Shs Outstand13.92M Perf Week-20.06%
Market Cap186.90M Forward P/E- EPS next Y-1.08 Insider Trans144.17% Shs Float2.53M Perf Month-38.68%
Income-68.80M PEG- EPS next Q- Inst Own1.00% Short Float6.48% Perf Quarter-55.95%
Sales- P/S- EPS this Y-598.00% Inst Trans- Short Ratio1.65 Perf Half Y25.02%
Book/sh0.94 P/B14.03 EPS next Y- ROA-841.70% Target Price- Perf Year317.41%
Cash/sh0.84 P/C15.71 EPS next 5Y- ROE- 52W Range3.50 - 46.10 Perf YTD-23.85%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-71.39% Beta1.94
Dividend %- Quick Ratio36.90 Sales past 5Y- Gross Margin- 52W Low276.86% ATR2.07
Employees2 Current Ratio36.90 Sales Q/Q- Oper. Margin- RSI (14)33.12 Volatility12.57% 12.03%
OptionableNo Debt/Eq0.01 EPS Q/Q-117.10% Profit Margin- Rel Volume1.22 Prev Close13.43
ShortableYes LT Debt/Eq0.01 Earnings- Payout- Avg Volume99.16K Price13.19
Recom2.00 SMA20-25.60% SMA50-47.27% SMA200-26.13% Volume120,616 Change-1.79%
Jan-15-21Initiated B. Riley Securities Buy $47
Mar-11-21 07:00AM  
Mar-09-21 07:00AM  
Feb-19-21 07:00AM  
Feb-02-21 08:30AM  
Oct-30-20 08:00AM  
Oct-29-20 08:00AM  
Sep-23-20 08:00AM  
Sep-21-20 07:00AM  
Sep-17-20 07:55PM  
Jun-16-20 08:30AM  
Jun-11-20 08:30AM  
Dec-09-19 08:00AM  
Oct-22-19 07:00AM  
BioVie Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of drugs therapies in the United States. It develops BIV201, which completed Phase 2a clinical trial for the treatment of ascites due to chronic liver cirrhosis. The company was formerly known as NanoAntibiotics, Inc. and changed its name to BioVie Inc. in July 2016. BioVie Inc. was founded in 2013 and is based in Santa Monica, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
GORLIN STEVEDirectorNov 03Buy7.952,43019,31845,100Dec 15 03:01 PM
GORLIN STEVEDirectorOct 30Buy7.972,57020,48342,670Dec 15 03:00 PM
GORLIN STEVEDirectorOct 21Buy9.195,00045,95040,100Oct 22 03:10 PM
GORLIN STEVEDirectorOct 15Buy10.195,10051,96725,100Oct 19 02:59 PM
GORLIN STEVEDirectorOct 15Buy10.0510,000100,55035,100Oct 19 02:59 PM
GORLIN STEVEDirectorOct 09Buy9.612822,71020,000Oct 14 02:07 PM
GORLIN STEVEDirectorOct 07Buy9.424,71844,44419,718Oct 14 02:05 PM
GORLIN STEVEDirectorSep 22Buy10.0015,000150,00015,000Oct 14 01:49 PM